Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07095972 · ClinicalTrials.gov registry record · NA

Continuous Glucose Monitoring in Metabolic Surgery

A NA study, sponsored by Pennington Biomedical Research Center.

Not yet
Registry status
NA
Development phase
20
Enrollment target

NCT07095972 is a NA study that has not yet begun recruiting, run by Pennington Biomedical Research Center. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07095972, a NA study, has not yet begun recruiting, sponsored by Pennington Biomedical Research Center.

NOT YET RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

We will recruit 20 severely obese participants at Metamor Institute. Participants with obesity who are eligible for MBS will be randomized to either CGM group or self-monitoring of blood glucose (SMBG) group before the surgery based on a 1:1 ratio. All participants live in Baton Rouge, Louisiana. The surgeon in Metamor will introduce our study to the patients. If the patients are interested, the evaluation process includes verifying basic personal information, assessing health status and medical history, and evaluating specific eligibility criteria relevant to the study. The study coordinator will be discussing informed consent, ensuring participants understand the study's purpose, procedures, and any associated risks or benefits. Participants are encouraged to ask questions, ensuring clarity and comfort with the study. All collected data is documented and securely stored, respecting data privacy protocols. Eligible individuals are informed about the screening visit, while those not suitable are considered for future studies.

Interventions

  • DEVICE Abbot Freestyle Libre CGM

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-08-15
Est. Completion 2027-08-31
Phase NA

What the Registry Record Tells You About NCT07095972

The ClinicalTrials.gov registry entry for NCT07095972 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Abbot Freestyle Libre CGM is the first listed.

NCT07095972 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07095972 about?

NCT07095972 is a clinical study titled "Continuous Glucose Monitoring in Metabolic Surgery". We will recruit 20 severely obese participants at Metamor Institute. Participants with obesity who are eligible for MBS will be randomized to either CGM group or self-monitoring of blood glucose (SMBG) group before the surgery based on a 1:1 ratio. All participants live in Baton Rouge, Louisiana. Th...

What is the current status of trial NCT07095972?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-08-15. Estimated completion is 2027-08-31.

What interventions are being tested in trial NCT07095972?

The interventions under investigation include: Abbot Freestyle Libre CGM (DEVICE).

Who is sponsoring clinical trial NCT07095972?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.